Cite
HARVARD Citation
Winter, R. et al. (2017). Higher 25‐hydroxyvitamin D levels are associated with greater odds of remission with anti‐tumour necrosis factor‐α medications among patients with inflammatory bowel diseases. Alimentary pharmacology & therapeutics. 45 (5), pp. 653-659. [Online].